CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,379,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-01 | Booth Andrew Chief Financial Officer | Grant or award · Share option (right to buy) | +808,898 | 8,751,849 | ||
| 2025-12-18 | Thermopylae Holdings Ltd. 10% owner | Gift | −225,000 | 55,918,640 | ||
| 2025-12-01 | Quake Stephen Director | Grant or award · Share option (right to buy) | +194,932 | 194,932 | ||
| 2025-11-26 | Montalbano John S. Director | Purchase | +50,000 | $3.57 | $178K | 221,000 |
| 2025-06-12 | Hayden Michael R Director | Grant or award · Share option (right to buy) | +238,864 | 899,843 | ||
| 2025-06-12 | Montalbano John S. Director | Grant or award · Share option (right to buy) | +238,864 | 1,029,843 | ||
| 2025-06-12 | Lo Andrew Director | Grant or award · Share option (right to buy) | +238,864 | 541,354 | ||
| 2025-03-11 | Thermopylae Holdings Ltd. 10% owner | Purchase | +343,631 | $2.16 | $742K | 56,143,640 |
| 2025-03-10 | Montalbano John S. Director | Purchase | +25,000 | $2.30 | $58K | 171,000 |
| 2025-03-06 | Montalbano John S. Director | Purchase | +60,000 | $2.34 | $141K | 146,000 |
| 2025-01-01 | Stimart Tryn Chief Legal Officer | Grant or award · Share option (right to buy) | +832,033 | 4,106,747 | ||
| 2025-01-01 | Lecault Veronique Chief Operating Officer | Grant or award · Share option (right to buy) | +832,033 | 4,661,804 | ||
| 2025-01-01 | Booth Andrew Chief Financial Officer | Grant or award · Share option (right to buy) | +1,352,054 | 7,942,951 | ||
| 2025-01-01 | Hansen Carl L. G. Chief Executive Officer | Grant or award · Share option (right to buy) | +2,730,109 | 10,990,332 | ||
| 2024-12-04 | Thermopylae Holdings Ltd. 10% owner | Gift | −286,000 | 55,800,009 | ||
| 2024-11-25 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 898,000 |
| 2024-11-25 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 8,260,223 | ||
| 2024-09-20 | Hansen Carl L. G. Chief Executive Officer | Option exercise | +56,125 | $2.70 | $152K | 841,875 |
| 2024-09-20 | Hansen Carl L. G. Chief Executive Officer | Option exercise · Share option (right to buy) | −56,125 | 8,316,348 | ||
| 2024-08-29 | Thermopylae Holdings Ltd. 10% owner | Purchase | +283,516 | $2.61 | $740K | 56,086,009 |
Page 2 of 11 · 203 trades